Financial Advocates Investment Management Moderna, Inc. Transaction History

Financial Advocates Investment Management

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$118.38 - $210.04 $133,769 - $237,345	1,130 New	1,130 $202,000
Q1 2022 May 11, 2022	SELL	$126.46 - $235.05 $183,619 - $341,292	-1,452 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$225.82 - $368.51 $1.38 Million - $2.25 Million	-6,095 Reduced 80.76%	1,452 $369,000
Q3 2021 Nov 04, 2021	BUY	$221.9 - $484.47 $1.24 Million - $2.7 Million	5,570 Added 281.74%	7,547 $2.9 Million
Q2 2021 Aug 03, 2021	SELL	$129.91 - $234.98 $91,716 - $165,895	-706 Reduced 26.31%	1,977 $464,000
Q1 2021 May 10, 2021	SELL	$109.18 - $185.98 $258,429 - $440,214	-2,367 Reduced 46.87%	2,683 $351,000
Q4 2020 Feb 12, 2021	SELL	$65.74 - $169.86 $334,682 - $864,757	-5,091 Reduced 50.2%	5,050 $1.84 Million
Q1 2020 Apr 29, 2020	BUY	$17.78 - $31.58 $180,306 - $320,252	10,141 New	10,141 $304,000

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Financial Advocates Investment Management, based on Form 13F filings with the SEC.

Stay updated on Financial Advocates Investment Management with notifications on news.